Choreographing Metastasis to the Tune of LTBP

被引:19
作者
Chandramouli, Anupama [2 ]
Simundza, Julia [1 ]
Pinderhughes, Alicia [1 ]
Cowin, Pamela [1 ,2 ]
机构
[1] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA
[2] NYU, Sch Med, Dept Dermatol, New York, NY 10016 USA
关键词
LTBP; TGF beta; Fibronectin; Metastasis; Mammary; Breast cancer; GROWTH-FACTOR-BETA; LATENT-TGF-BETA; MAMMARY-GLAND DEVELOPMENT; BREAST-CANCER METASTASIS; ABNORMAL LUNG DEVELOPMENT; BINDING-PROTEIN; EXTRACELLULAR-MATRIX; II RECEPTOR; IN-VIVO; MICROFIBRIL ORGANIZATION;
D O I
10.1007/s10911-011-9215-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Latent Transforming Growth Factor beta (TGF beta) Binding Proteins (LTBPs) are chaperones and determinants of TGF beta isoform-specific secretion. They belong to the LTBP/Fibrillin family and form integral components of the fibronectin and microfibrillar extracellular matrix (ECM). LTBPs serve as master regulators of TGF beta bioavailability, functioning to incorporate and spatially pattern latent TGF beta at regular intervals within the ECM, and actively participate in integrin-mediated stretch activation of TGF beta in vivo. In so doing they create a highly patterned sensory system where local changes in ECM tension can be detected and transduced into focal signals. The physiological role of LTBPs in the mammary gland remains largely unstudied, however both loss and gain of LTBP expression is found in breast cancers and breast cancer cell lines. Importantly, elevated LTBP1 levels appear in two gene signatures predictive of enhanced metastatic behavior. LTBP may promote metastasis by providing the bridge between structural and signaling components of the epithelial to mesenchymal transition (EMT).
引用
收藏
页码:67 / 80
页数:14
相关论文
共 111 条
[1]   EFFECTS OF LETS GLYCOPROTEIN ON CELL MOTILITY [J].
ALI, IU ;
HYNES, RO .
CELL, 1978, 14 (02) :439-446
[2]   Null Mutations in LTBP2 Cause Primary Congenital Glaucoma [J].
Ali, Manir ;
McKibbin, Martin ;
Booth, Adam ;
Parry, David A. ;
Jain, Payal ;
Riazuddin, S. Amer ;
Hejtmancik, J. Fielding ;
Khan, Shaheen N. ;
Firasat, Sabika ;
Shires, Mike ;
Gilmour, David F. ;
Towns, Katherine ;
Murphy, Anna-Louise ;
Azmanov, Dimitar ;
Tournev, Ivailo ;
Cherninkova, Sylvia ;
Jafri, Hussain ;
Raashid, Yasmin ;
Toomes, Carmel ;
Craig, Jamie ;
Mackey, David A. ;
Kalaydjieva, Luba ;
Riazuddin, Sheikh ;
Inglehearn, Chris F. .
AMERICAN JOURNAL OF HUMAN GENETICS, 2009, 84 (05) :664-671
[3]   Mice that lack activity of αvβ6-and αvβ8-integrins reproduce the abnormalities of Tgfb1- and Tgfb3-null mice [J].
Aluwihare, Poshala ;
Mu, Zhenyu ;
Zhao, Zhicheng ;
Yu, Dawen ;
Weinreb, Paul H. ;
Horan, Gerald S. ;
Violette, Shelia M. ;
Munger, John S. .
JOURNAL OF CELL SCIENCE, 2009, 122 (02) :227-232
[4]   Integrin αvβ6-mediated activation of latent TGF-β requires the latent TGF-β binding protein-1 [J].
Annes, JP ;
Chen, Y ;
Munger, JS ;
Rifkin, DB .
JOURNAL OF CELL BIOLOGY, 2004, 165 (05) :723-734
[5]   Making sense of latent TGFβ activation [J].
Annes, JP ;
Munger, JS ;
Rifkin, DB .
JOURNAL OF CELL SCIENCE, 2003, 116 (02) :217-224
[6]   The integrin αVβ6 binds and activates latent TGFβ3 [J].
Annes, JP ;
Rifkin, DB ;
Munger, JS .
FEBS LETTERS, 2002, 511 (1-3) :65-68
[7]   Integrin-mediated transforming growth factor-β activation regulates homeostasis of the pulmonary epithelial-mesenchymal trophic unit [J].
Araya, Jun ;
Cambier, Stephanie ;
Morris, Alanna ;
Finkbeiner, Walter ;
Nishimura, Stephen L. .
AMERICAN JOURNAL OF PATHOLOGY, 2006, 169 (02) :405-415
[8]   Increased expression of integrin αvβ3 contributes to the establishment of autocrine TGF-β signaling in scleroderma fibroblasts [J].
Asano, Y ;
Ihn, H ;
Yamane, K ;
Jinnin, M ;
Mimura, Y ;
Tamaki, K .
JOURNAL OF IMMUNOLOGY, 2005, 175 (11) :7708-7718
[9]   Latency and Activation in the Control of TGF-β [J].
Barcellos-Hoff, Mary Helen .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1996, 1 (04) :353-363
[10]   TRANSFORMING GROWTH-FACTOR-BETA ACTIVATION IN IRRADIATED MARINE MAMMARY-GLAND [J].
BARCELLOSHOFF, MH ;
DERYNCK, R ;
TSANG, MLS ;
WEATHERBEE, JA .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (02) :892-899